Vifor Pharma Group has expanded its presence in nephrology with the acquisition of two companies with therapies addressing specific aspects of vascular calcification. The companies are Sanifit Therapeutics SA of Spain and Inositec AG of Switzerland. ---Subscribe to MedNous to access this article--- Clinical Research Company News Finance, Grants, Deals
